Search Results

Ki20227 2 mg  | 97.16%

TargetMol

Ki-20227 is a specific c-Fms tyrosine kinase(CSF1R) inhibitor (IC50: 2 nM). It also has certain inhibitory against VEGFR2(IC50: 12 nM) and c-Kit/PDGFRβ(IC50: 451/217 nM), respectively.

More Information Supplier Page

Ki20227 1 mg  | 97.16%

TargetMol

Ki-20227 is a specific c-Fms tyrosine kinase(CSF1R) inhibitor (IC50: 2 nM). It also has certain inhibitory against VEGFR2(IC50: 12 nM) and c-Kit/PDGFRβ(IC50: 451/217 nM), respectively.

More Information Supplier Page

YU238259 2 mg  | 99.43%

TargetMol

YU238259 is a novel inhibitor of homology-dependent DNA repair(HDR), but does not inhibit non-homologous end-joining (NHEJ), in cell-based GFP reporter assays.

More Information Supplier Page

YU238259 5 mg  | 99.43%

TargetMol

YU238259 is a novel inhibitor of homology-dependent DNA repair(HDR), but does not inhibit non-homologous end-joining (NHEJ), in cell-based GFP reporter assays.

More Information Supplier Page

YU238259 10 mg  | 99.43%

TargetMol

YU238259 is a novel inhibitor of homology-dependent DNA repair(HDR), but does not inhibit non-homologous end-joining (NHEJ), in cell-based GFP reporter assays.

More Information Supplier Page

CBL0137 hydrochloride 50 mg  | 98.59%

TargetMol

CBL0137 activates p53 and inhibits NF-kB (EC50: 0.37/0.47 μM) in the cell-based p53 and NF-kB reporter assays, respectively. It also suppresses histone chaperone FACT.

More Information Supplier Page

CBL0137 hydrochloride 25 mg  | 98.59%

TargetMol

CBL0137 activates p53 and inhibits NF-kB (EC50: 0.37/0.47 μM) in the cell-based p53 and NF-kB reporter assays, respectively. It also suppresses histone chaperone FACT.

More Information Supplier Page

CBL0137 hydrochloride 10 mg  | 98.59%

TargetMol

CBL0137 activates p53 and inhibits NF-kB (EC50: 0.37/0.47 μM) in the cell-based p53 and NF-kB reporter assays, respectively. It also suppresses histone chaperone FACT.

More Information Supplier Page